vs

Side-by-side financial comparison of A. O. Smith (AOS) and ResMed (RMD). Click either name above to swap in a different company.

ResMed is the larger business by last-quarter revenue ($1.4B vs $912.5M, roughly 1.6× A. O. Smith). ResMed runs the higher net margin — 27.6% vs 13.7%, a 13.9% gap on every dollar of revenue. On growth, ResMed posted the faster year-over-year revenue change (11.0% vs 0.0%). Over the past eight quarters, ResMed's revenue compounded faster (7.9% CAGR vs -3.4%).

A. O. Smith Corporation is an American manufacturer of both residential and commercial water heaters and boilers, and the largest manufacturer and marketer of water heaters in North America. It also supplies water treatment and purification products in the Asian market. The company has 27 locations worldwide, including five manufacturing facilities in North America, as well as plants in Bengaluru in India, Nanjing in China and Veldhoven in The Netherlands.

ResMed Inc. is a medical equipment company based in San Diego, California, and founded in Australia. It primarily provides cloud-connectable medical devices for the treatment of sleep apnea, chronic obstructive pulmonary disease (COPD), and other respiratory conditions. Resmed produced hundreds of thousands of ventilators and bilevel devices to help treat the respiratory symptoms of patients with COVID-19.

AOS vs RMD — Head-to-Head

Bigger by revenue
RMD
RMD
1.6× larger
RMD
$1.4B
$912.5M
AOS
Growing faster (revenue YoY)
RMD
RMD
+11.0% gap
RMD
11.0%
0.0%
AOS
Higher net margin
RMD
RMD
13.9% more per $
RMD
27.6%
13.7%
AOS
Faster 2-yr revenue CAGR
RMD
RMD
Annualised
RMD
7.9%
-3.4%
AOS

Income Statement — Q4 FY2025 vs Q4 FY2026

Metric
AOS
AOS
RMD
RMD
Revenue
$912.5M
$1.4B
Net Profit
$125.4M
$392.6M
Gross Margin
38.4%
61.8%
Operating Margin
17.9%
34.6%
Net Margin
13.7%
27.6%
Revenue YoY
0.0%
11.0%
Net Profit YoY
14.3%
13.9%
EPS (diluted)
$0.89
$2.68

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AOS
AOS
RMD
RMD
Q2 26
$1.4B
Q4 25
$912.5M
$1.4B
Q3 25
$942.5M
$1.3B
Q2 25
$1.0B
$1.3B
Q1 25
$963.9M
$1.3B
Q4 24
$912.4M
$1.3B
Q3 24
$902.6M
$1.2B
Q2 24
$1.0B
$1.2B
Net Profit
AOS
AOS
RMD
RMD
Q2 26
$392.6M
Q4 25
$125.4M
$392.6M
Q3 25
$132.0M
$348.5M
Q2 25
$152.2M
$379.7M
Q1 25
$136.6M
$365.0M
Q4 24
$109.7M
$344.6M
Q3 24
$120.1M
$311.4M
Q2 24
$156.2M
$292.2M
Gross Margin
AOS
AOS
RMD
RMD
Q2 26
61.8%
Q4 25
38.4%
61.8%
Q3 25
38.7%
61.5%
Q2 25
39.3%
60.8%
Q1 25
38.9%
59.3%
Q4 24
37.1%
58.6%
Q3 24
37.4%
58.6%
Q2 24
38.7%
58.5%
Operating Margin
AOS
AOS
RMD
RMD
Q2 26
34.6%
Q4 25
17.9%
34.6%
Q3 25
18.6%
33.4%
Q2 25
20.4%
33.7%
Q1 25
19.1%
33.0%
Q4 24
10.1%
32.5%
Q3 24
19.5%
31.6%
Q2 24
21.9%
31.2%
Net Margin
AOS
AOS
RMD
RMD
Q2 26
27.6%
Q4 25
13.7%
27.6%
Q3 25
14.0%
26.1%
Q2 25
15.0%
28.2%
Q1 25
14.2%
28.3%
Q4 24
12.0%
26.9%
Q3 24
13.3%
25.4%
Q2 24
15.2%
23.9%
EPS (diluted)
AOS
AOS
RMD
RMD
Q2 26
$2.68
Q4 25
$0.89
$2.68
Q3 25
$0.94
$2.37
Q2 25
$1.07
$2.58
Q1 25
$0.95
$2.48
Q4 24
$0.75
$2.34
Q3 24
$0.82
$2.11
Q2 24
$1.06
$1.97

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AOS
AOS
RMD
RMD
Cash + ST InvestmentsLiquidity on hand
$193.2M
$1.4B
Total DebtLower is stronger
$155.0M
$663.8M
Stockholders' EquityBook value
$1.9B
$6.3B
Total Assets
$3.1B
$8.5B
Debt / EquityLower = less leverage
0.08×
0.11×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AOS
AOS
RMD
RMD
Q2 26
$1.4B
Q4 25
$193.2M
$1.4B
Q3 25
$172.8M
$1.4B
Q2 25
$177.9M
$1.2B
Q1 25
$200.2M
$932.7M
Q4 24
$276.1M
$521.9M
Q3 24
$255.6M
$426.4M
Q2 24
$233.3M
$238.4M
Total Debt
AOS
AOS
RMD
RMD
Q2 26
$663.8M
Q4 25
$155.0M
$403.9M
Q3 25
$408.7M
Q2 25
$658.4M
Q1 25
$663.1M
Q4 24
$193.2M
$662.9M
Q3 24
$667.6M
Q2 24
$697.3M
Stockholders' Equity
AOS
AOS
RMD
RMD
Q2 26
$6.3B
Q4 25
$1.9B
$6.3B
Q3 25
$1.8B
$6.1B
Q2 25
$1.8B
$6.0B
Q1 25
$1.9B
$5.5B
Q4 24
$1.9B
$5.3B
Q3 24
$1.9B
$5.2B
Q2 24
$1.9B
$4.9B
Total Assets
AOS
AOS
RMD
RMD
Q2 26
$8.5B
Q4 25
$3.1B
$8.5B
Q3 25
$3.2B
$8.3B
Q2 25
$3.2B
$8.2B
Q1 25
$3.3B
$7.6B
Q4 24
$3.2B
$7.1B
Q3 24
$3.2B
$7.2B
Q2 24
$3.2B
$6.9B
Debt / Equity
AOS
AOS
RMD
RMD
Q2 26
0.11×
Q4 25
0.08×
0.06×
Q3 25
0.07×
Q2 25
0.11×
Q1 25
0.12×
Q4 24
0.10×
0.13×
Q3 24
0.13×
Q2 24
0.14×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AOS
AOS
RMD
RMD
Operating Cash FlowLast quarter
$183.1M
Free Cash FlowOCF − Capex
$165.5M
FCF MarginFCF / Revenue
18.1%
Capex IntensityCapex / Revenue
1.9%
Cash ConversionOCF / Net Profit
1.46×
TTM Free Cash FlowTrailing 4 quarters
$546.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AOS
AOS
RMD
RMD
Q2 26
Q4 25
$183.1M
$339.7M
Q3 25
$255.4M
$457.3M
Q2 25
$139.6M
$538.8M
Q1 25
$38.7M
$578.7M
Q4 24
$221.9M
$308.6M
Q3 24
$195.9M
$325.5M
Q2 24
$57.4M
$440.1M
Free Cash Flow
AOS
AOS
RMD
RMD
Q2 26
Q4 25
$165.5M
$311.2M
Q3 25
$240.6M
$414.4M
Q2 25
$122.5M
$508.2M
Q1 25
$17.4M
$557.9M
Q4 24
$191.3M
$288.0M
Q3 24
$163.4M
$307.7M
Q2 24
$34.5M
$415.2M
FCF Margin
AOS
AOS
RMD
RMD
Q2 26
Q4 25
18.1%
21.9%
Q3 25
25.5%
31.0%
Q2 25
12.1%
37.7%
Q1 25
1.8%
43.2%
Q4 24
21.0%
22.5%
Q3 24
18.1%
25.1%
Q2 24
3.4%
33.9%
Capex Intensity
AOS
AOS
RMD
RMD
Q2 26
Q4 25
1.9%
2.0%
Q3 25
1.6%
3.2%
Q2 25
1.7%
2.3%
Q1 25
2.2%
1.6%
Q4 24
3.4%
1.6%
Q3 24
3.6%
1.5%
Q2 24
2.2%
2.0%
Cash Conversion
AOS
AOS
RMD
RMD
Q2 26
Q4 25
1.46×
0.87×
Q3 25
1.93×
1.31×
Q2 25
0.92×
1.42×
Q1 25
0.28×
1.59×
Q4 24
2.02×
0.90×
Q3 24
1.63×
1.05×
Q2 24
0.37×
1.51×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AOS
AOS

North America Segment$713.7M78%
Rest Of World$158.3M17%
Other$40.5M4%

RMD
RMD

Segment breakdown not available.

Related Comparisons